FDA Scientists Pressured to Exclude, Alter Findings; Scientists Fear Retaliation for Voicing Safety Concerns
The Union of Concerned Scientists (UCS) today released survey results that demonstrate pervasive and dangerous political influence of science at the Food and Drug Administration (FDA). Of the 997 FDA scientists who responded to the survey, nearly one-fifth (18.4 percent) said that they "have been asked, for non-scientific reasons, to inappropriately exclude or alter technical information or their conclusions in a FDA scientific document."
Public Health and Safety Will Suffer without
Leadership from FDA and Congress
UCS, July 20,
2006
http://tinyurl.com/hehhc
WASHINGTON,
DC - The Union of Concerned Scientists (UCS) today released survey results that
demonstrate pervasive and dangerous political influence of science at the Food
and Drug Administration (FDA). Of the 997 FDA scientists who responded to the
survey, nearly one-fifth (18.4 percent) said that they "have been asked, for
non-scientific reasons, to inappropriately exclude or alter technical
information or their conclusions in a FDA scientific document." This is the
third survey UCS has conducted to examine inappropriate interference with
science at federal agencies.
"Science must be the driving
force for decisions made at the FDA. These disturbing survey results make it
clear that inappropriate interference is putting people in harm's way," said Dr.
Francesca Grifo, Senior Scientist and Director of UCS's Scientific Integrity
Program. "FDA leaders should act now to improve transparency and accountability
and renew respect for independent science at the agency."
The UCS survey,
which was co-sponsored by Public Employees for Environmental Responsibility, was
sent to 5,918 FDA scientists. Forty percent of respondents fear retaliation for
voicing safety concerns in public. This fear, scientists say, combines with
other pressures to compromise the agency's ability to protect public health and
safety. More than a third of the respondents did not feel they could express
safety concerns even inside the agency.
"This is more than just a
bureaucratic problem within the agency," said Kim Witczak, WoodyMatters.com, who
lost her husband due to side effects of a dangerous anti-depressant.
"It
has real human impacts which can be devastating. My husband paid the ultimate
price for FDA's lack of accountability."
The survey also revealed other
compelling points of concern:
61 percent of the respondents knew of
cases where "Department of Health and Human Services or FDA political appointees
have inappropriately injected themselves into FDA determinations or actions."
Only 47 percent think the "FDA routinely provides complete and accurate
information to the public."
81 percent agreed that the "public would be
better served if the independence and authority of FDA post-market safety
systems were strengthened."
70 percent disagree with the statement that FDA
has sufficient resources to perform effectively its mission of "protecting
public health…and helping to get accurate science-based information they need to
use medicines and foods to improve their health."
"The FDA regulates products
vital to the well-being of all Americans, including food, drugs, vaccines, and
medical devices," said Dr. Grifo. "To fully protect public health and safety,
the FDA must have the best available independent scientific data."
To
address the concerns raised by FDA scientists, UCS recommends:
–
Accountability: FDA leadership must face consequences if they side with
commercial or political interests and not with the American
people.
– Transparency: Scientific research and reviews should be
open so any undue manipulation is immediately apparent.
–
Protection: Safeguards must be put in place for all government scientists who
speak out.
"What we see at the FDA, while dramatic and frightening, is
all too common at many federal agencies," said Dr. Grifo. "All federal
scientists need protections so they can speak out when their science is
manipulated, and all federal agencies need fully functioning independent
advisory committees. FDA leadership must understand and support independent
science and it is up to Congress to hold them accountable."
